Summit X LLC boosted its position in UnitedHealth Group Inc (NYSE:UNH) by 4.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,186 shares of the healthcare conglomerate’s stock after buying an additional 236 shares during the quarter. Summit X LLC’s holdings in UnitedHealth Group were worth $1,533,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of the business. Capital World Investors increased its position in shares of UnitedHealth Group by 7.2% during the fourth quarter. Capital World Investors now owns 47,932,997 shares of the healthcare conglomerate’s stock worth $14,091,342,000 after acquiring an additional 3,219,554 shares during the last quarter. State Street Corp grew its stake in UnitedHealth Group by 0.5% during the 1st quarter. State Street Corp now owns 46,003,796 shares of the healthcare conglomerate’s stock valued at $11,472,427,000 after purchasing an additional 212,240 shares in the last quarter. Capital Research Global Investors increased its holdings in UnitedHealth Group by 32.1% during the 4th quarter. Capital Research Global Investors now owns 29,851,016 shares of the healthcare conglomerate’s stock worth $8,775,602,000 after purchasing an additional 7,261,158 shares during the last quarter. Capital International Investors raised its position in shares of UnitedHealth Group by 4.4% in the 4th quarter. Capital International Investors now owns 25,843,701 shares of the healthcare conglomerate’s stock valued at $7,597,531,000 after purchasing an additional 1,082,141 shares in the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of UnitedHealth Group by 3.7% during the 4th quarter. Geode Capital Management LLC now owns 13,371,451 shares of the healthcare conglomerate’s stock valued at $3,922,552,000 after buying an additional 471,331 shares during the last quarter. 86.59% of the stock is owned by institutional investors.
In other news, Director Stephen J. Hemsley sold 45,637 shares of UnitedHealth Group stock in a transaction on Monday, May 11th. The stock was sold at an average price of $289.11, for a total transaction of $13,194,113.07. Following the transaction, the director now owns 1,013,122 shares in the company, valued at $292,903,701.42. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard T. Burke sold 5,000 shares of the company’s stock in a transaction dated Monday, March 16th. The shares were sold at an average price of $237.00, for a total value of $1,185,000.00. Following the completion of the transaction, the director now owns 1,406,500 shares in the company, valued at approximately $333,340,500. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 65,637 shares of company stock valued at $17,723,013. 0.80% of the stock is currently owned by corporate insiders.
UNH traded down $0.81 on Tuesday, reaching $305.12. The company had a trading volume of 123,802 shares, compared to its average volume of 4,151,920. The company has a market capitalization of $290.14 billion, a P/E ratio of 21.38, a PEG ratio of 1.50 and a beta of 0.72. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 0.60. The company has a fifty day moving average of $287.94 and a 200-day moving average of $279.33. UnitedHealth Group Inc has a one year low of $187.72 and a one year high of $309.66.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Wednesday, April 15th. The healthcare conglomerate reported $3.72 earnings per share for the quarter, topping analysts’ consensus estimates of $3.63 by $0.09. UnitedHealth Group had a net margin of 5.59% and a return on equity of 24.86%. The company had revenue of $64.40 billion during the quarter, compared to analyst estimates of $64.25 billion. During the same period in the prior year, the business posted $3.73 EPS. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. Research analysts predict that UnitedHealth Group Inc will post 16.24 EPS for the current year.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: What is a put option?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.